Sequence variation in the hypervariable region 1 of hepatitis C virus and posttransplantation recurrent hepatitis

Liver Transplantation

Volumn 9, Issue 10, 2003, Pages 1040-1047

  Silini, Enrico ^a   Belli, Luca ^b   Brambilla, Sabrina ^a   Foti, Luciana ^c   Gritti, Chiara ^c   Lisa, Antonella ^d   Alberti, Alberto Battista ^b   Vinci, Marilina ^b   De Carlis, Luciano ^b   Rondinara, Gianfranco ^b   Pinzello, Giovanbattista ^b  

^a IRCCS Policlinico S   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c Associazione Studio Avanzato Epatiti   (Italy)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INTERFERON; PREDNISOLONE; RIBAVIRIN; THYMOCYTE ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC PROCEDURES; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOGLOBULIN VARIABLE REGION; LIVER TRANSPLANTATION; MALE; MOLECULAR CLONING; PHYLOGENY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION; TREATMENT OUTCOME;

EID: 10744226064     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50180     Document Type: Article

References (39)

1. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 1992;66:3225-3229.
2. Domingo E. Biological significance of viral quasispecies. Viral Hep Rev 1996;2:247-261.
3. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997;99:1472-1477.
4. Domingo E, Holland JJ. RNA virus mutations and fitness for survival. Ann Rev Microbiol 1997;51:151-178.
5. Coffin JM. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis and therapy. Science 1995;267: 483-489.
6. Brambilla S, Bellati G, Asti M, Lisa A, Candusso ME, D'Amico M, et al. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease. Hepatology 1998;27:1678-1686.
7. Mondelli MU, Cerino A, Lisa A, Brambilla S, Segagni L, Cividini A, et al. Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation. Hepatology 1999;30:537-545.
8. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002;8(suppl):S14-S18.
9. Belli LS, Silini E, Alberti AB, Bellati G, Vai C, Minola E, et al. Hepatitis C virus genotypes, hepatitis and hepatitis C virus recurrence after liver transplantation. Liver Transpl 1996;2:200-205.
10. Belli LS, De Carlis L, Rondinara G, Alberti AB, Bellati G, De Gasperi A, et al. Early cyclosporine monotherapy in liver transplantation: A 5-year follow-up of a prospective, randomized trial. Hepatology 1998;27:1524-1529.
11. Belli LS, Zavaglia C, Alberti AB, Poli F, Rondinara GF, Silini E, et al. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation. Hepatology 2000;31:1345-1350.
12. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
13. Silini EM, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995;21:285-290.
14. Felsenstein J. PHYLIP manual, version 3.5c. Seattle, WA: University of Washington, 1990.
15. Kimura M. Estimation of evolutionary distances between homologous nucleotide sequences. Proc Natl Acad Sci U S A 1981;78:454-458.
16. Holland JJ, De la Torre JC, Steinhauer DA. RNA virus populations as quasispecies. Curr Topics Microbiol Immunol 1992; 176:1-20.
17. Smith DB, McAllister J, Casino C, Simmonds P. Virus 'quasispecies': Making a mountain out of a molehill? J Gen Virol 1997;78:1511-1519.
18. Collier J, Heathcote J. Hepatitis C viral infection in the immunosuppressed patient. Hepatology 1998;27:2-6.
19. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996;70:7622-7631.
20. Sullivan DG, Wilson JJ, Carithers RL, Perkins JD, Gretch DR. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: Correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1998;72:10036-10043.
21. Holmes EC, Zhang LQ, Simmonds P, Ludlam CA, Leigh Brown AJ. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A 1992;89:4835-4839.
22. Lyra AC, Fan X, Lang DM, Yusim K, Ramrakhiani S, Brunt EM, et al. Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology 2002;123:1485-1493.
23. Martell M, Esteban JI, Quer J, Vargas V, Esteban R, Guardia J, et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994;68:3425-3436.
24. Sànchez-Fueyo A, Giménez-Barcons M, Puig-Basagoiti F, Rimola A, Sànchez-Tapias JM, Sàiz JC, et al. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J Med Virol 2001;65:266-275.
25. Pelletier SJ, Raymond DP, Crabtree TD, Iezzoni JC, Sawyer RG, Hahn YS, et al. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation. Hepatology 2000;32:375-381.
26. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy. Science 1998;282:103-107.
27. Fukumoto T, Berg T, Ku Y, Bechstein WO, Knoop M, Lemmens H-P, et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions. Hepatology 1996;24:1351-1354.
28. Garcia-Retortillo M, Forns X, Moitinho E, Costa J, Navasa M, Rimola A, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002;35:680-687.
29. Di Martino V, Saurini F, Samuel D, Gigou M, Dussaix E, Reynes M, et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 1997;26:1343-1350.
30. + T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease. J Infect Dis 2001;183:1187-1194.
31. Feray C, Caccamo L, Alexander GJM, Ducot B, Gugenheim J, Casanovas T, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999;117:619-625.
32. + responses to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 1999;117:926-932.
33. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000;32:1125-1130.
34. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JYN, Simmonds P, et al. Severity of liver diseases in liver transplantation recipients with hepatitis C virus infection: Relationship to genotype and level of viremia. Hepatology 1996;24:1041-1046.
35. Everson GT. Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl 2002;8 (suppl):S19-S27.
36. McCaughan GW, Zekry A. Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl 2002;8(suppl):S7-S13.
37. + T-cell response in acute hepatitis C. Gastroenterology 1999;117:933-941.
38. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000;288:339-344.
39. Gane E. Treatment of recurrent hepatitis C. Liver Transpl 2002; 8(suppl):S28-S37.